Seaport Therapeutics Expanded Access Policy

 

Seaport Therapeutics is focused on conducting clinical trials to study the safety and efficacy of our investigational product candidates. These clinical trials are necessary for obtaining regulatory approval.

We believe that participation in clinical trials is the most appropriate way for patients to access our product candidates before they are approved by a regulatory authority, and we believe regulatory approval is the best way to make safe and effective medications available to patients who may benefit. Patients should speak with their physician to determine if an investigational medical therapy is right for them.

At this time, we do not offer any Expanded Access programs. We may reassess this position in the future.

To learn more about our ongoing clinical trials, please visit our study postings on ClinicalTrials.gov.

If you are a physician interested in learning more about our investigational products, please contact clinicaltrials@seaporttx.com.
We aim to respond to inquiries within five (5) business days.

This policy is subject to change by Seaport Therapeutics at any time. Please check the Site periodically for updates. 

 

Seaport Therapeutics 101 Seaport Blvd Seaport Boston, MA 02210

info@seaporttx.com

© 2026 Seaport Therapeutics

Seaport Therapeutics
101 Seaport Blvd, Floor 12
Seaport Boston, MA 02210